在喘中使用ICS和快速起作用的支气管扩展剂:过去,现在和未来
The Journal of family practice
|August 7, 2023
概括
初级保健喘管理面临挑战,但新的吸入性皮质类固醇 (ICS) 和短效β2-激动剂 (SABA) 救援吸入器提供了更好的控制和减少恶化. 这通过利用快速的ICS作用和患者偏好来推进喘治疗.
科学领域:
- 肺部病理学 肺部病理学
- 主要护理医学 医疗保健
- 药理学 药理学是指药理学的学科.
背景情况:
- 大多数喘患者在初级保健中得到治疗,但仍然存在严重的护理差距,导致高恶化率.
- 挑战包括不受控制的喘,不充分的评估,过度依赖短效β2-激动剂 (SABA) 或全身皮质类固醇 (SCS),以及对维持治疗的不良坚持.
- 最近的证据表明,吸入性皮质类固醇 (ICS) 具有快速起作用,挑战了以前的假设.
研究的目的:
- 在初级保健机构内审查喘管理当前的挑战.
- 突出ICS的快速起作用以及ICS + 快速起作用的支气管扩展剂治疗对缓解症状和减少恶化的益处.
- 强调以患者为中心的护理的重要性以及最近批准的SABA-ICS组合救援吸入器.
主要方法:
- 审查关于喘管理,恶化和治疗策略的当前文献.
- 对吸入性皮质类固醇 (ICS) 的作用及其作用开始的分析.
- 讨论新批准的SABA-ICS组合救援吸入器的影响.
主要成果:
- 吸入性皮质类固醇 (ICS) 对支气管组织具有快速作用,在几秒到几分钟内发生.
- 结合治疗ICS和快速起作用的支气管扩展剂,根据需要用于症状,改善喘控制和降低恶化率.
- 根据需要使用的SABA-ICS组合吸入器于2023年1月获得批准,以减少恶化风险.
结论:
- 在症状发作期间,ICS + 快速起作用的支气管扩展剂的早期干预可以预防恶化,并减少对全身皮质类固醇 (SCS) 的依赖.
- 将患者的偏好纳入喘管理计划可以提高参与度和改善结果.
- 萨巴-ICS组合救援吸入器的出现代表了在初级保健中控制喘和预防恶化方面取得的重大进展.
相关概念视频
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
299
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
299
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
302
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
302
01:23Inhaled Medications
309
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
309
01:17Drugs Used in Lower Respiratory Disorders: Overview
489
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
489
01:26COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244